Scaling up HIV treatment in Peru: applying lessons from DOTS-Plus

J Int Assoc Physicians AIDS Care (Chic). 2006 Dec;5(4):137-42. doi: 10.1177/1545109706291394.

Abstract

Many countries with financial support for HIV treatment experience delays in scale-up because of bureaucratic, operational, and technical obstacles. The authors describe the Peruvian National HIV Program's response to such challenges. A team of consultants experienced in the scale-up of the Peruvian national program to treat multidrug-resistant tuberculosis worked with the national HIV program to identify and address key factors contributing to slow enrollment of HIV patients into the antiretroviral treatment program. The rate of enrollment into the antiretroviral treatment program increased from 124 patients/month in the first 9 months of the program to 226 patients/month in the last 7 months, an increase of 83%. This strategy achieved 38.5% coverage of the population in need. Effective programmatic expansion of the Peruvian National HIV Program was facilitated by a multidisciplinary collaboration in a systematized effort to overcome barriers to scale-up.

MeSH terms

  • Anti-Retroviral Agents / economics
  • Anti-Retroviral Agents / supply & distribution
  • Anti-Retroviral Agents / therapeutic use
  • Delivery of Health Care / methods
  • Delivery of Health Care / organization & administration*
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • Humans
  • Patient Compliance
  • Peru / epidemiology
  • Preventive Health Services / economics
  • Preventive Health Services / organization & administration
  • Preventive Health Services / standards*

Substances

  • Anti-Retroviral Agents